Spectral AI, Inc. Class A Common Stock (MDAI) is a publicly traded Healthcare sector company. As of May 21, 2026, MDAI trades at $2.43 with a market cap of $71.29M and a P/E ratio of -4.57. MDAI moved +2.95% today. Year to date, MDAI is +52.83%; over the trailing twelve months it is +78.68%. Its 52-week range spans $0.96 to $3.25. Analyst consensus is buy with an average price target of $4.50. Rallies surfaces MDAI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Spectral AI’s DeepView System Wins Inaugural Texas Innovator Award: Spectral AI received the Small Business Innovator Award at the inaugural Texas Innovation Conference on April 22-23, 2026, for its DeepView System. The AI-driven device combines multispectral imaging with a proprietary algorithm to predict burn wound healing potential and submitted its De Novo clearance application in June 2025.
| Metric | Value |
|---|---|
| Price | $2.43 |
| Market Cap | $71.29M |
| P/E Ratio | -4.57 |
| EPS | $-0.53 |
| Dividend Yield | 0.00% |
| 52-Week High | $3.25 |
| 52-Week Low | $0.96 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $16.93M |
| Net Income | $-13.88M |
| Gross Margin | 45.97% |
2 analysts cover MDAI: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $4.50.